CellDx-Tissue— 510(k) K260235
Substantially EquivalentDatar Cancer Genetics Private Limited
FDA 510(k) clearance K260235 for CellDx-Tissue, Substantially Equivalent on 2026-05-12. Applicant: Datar Cancer Genetics Private Limited. Device class: 2.
Clearance details
- Applicant
- Datar Cancer Genetics Private Limited
- Product code
- Code PZM
- Device class
- Class 2
- Regulation
- 21 CFR 866.6080
- Advisory panel
- Pathology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Nasik, IN
Recent devices under product code PZM
view allData sourced from openFDA. This site is unofficial and independent of the FDA.